Bunge Global SA (BG) Stock Price & Analysis
Bunge Global SA (BG) closed at USD 103.15 on Thursday, October 22, 2026, up 0.90% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 102.23; the Oct 22, 2026 session ranged USD 100.5–103.2 on volume of 1,332,021 shares. Market capitalization is $19.82B, with a 52-week range of USD 88.24–134.87 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BG.md
Key facts (BG)
- Last four reported quarters (through Jun 30, 2026): revenue $91.8B, net income $1.01B (1.1% margin), free cash flow -$711M (SEC filings).
- Valuation: P/E 19.7x (avg 11.6x at the last 3 fiscal year-ends), net debt $9.84B.
- 1 of 80 tracked superinvestors hold BG (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.78 on a 1–5 scale) (9 analysts), mean target USD 140.56 (range 116–155).
- Total return with dividends: 1Y +9.4% vs S&P 500 +14.9%; 5Y +33.5% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 2.42, revenue estimate $22.8B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BG)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $59.2B | $67.2B | $59.5B | $53.1B | $70.3B | $91.8B |
| Gross profit | $3.36B | $3.68B | $4.84B | $3.39B | $3.41B | — |
| Net income | $2.08B | $1.61B | $2.24B | $1.14B | $816M | $1.01B |
| EPS (diluted) | $13.64 | $10.51 | $14.87 | $7.99 | $4.91 | — |
| Free cash flow | -$3.29B | -$6.10B | $2.19B | $524M | -$879M | -$711M |
| Gross margin | 5.7% | 5.5% | 8.1% | 6.4% | 4.8% | — |
| Net margin | 3.5% | 2.4% | 3.8% | 2.1% | 1.2% | 1.1% |
| Revenue growth | — | +13.7% | -11.4% | -10.8% | +32.4% | — |
| Cash + short-term investments | $902M | $1.22B | $2.71B | $3.79B | $2.00B | — |
| Total debt | — | $4.11B | $4.08B | $5.36B | $10.2B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BG)
P/E 19.7x · P/S 0.2x · EV/Sales 0.3x · P/B 1.2x · FCF yield -3.59% · Earnings yield 5.08% · Dividend yield (paid, TTM) 2.77% · Net debt $9.84B · EV $29.7B
P/E at fiscal year-ends: Dec 2025 18.2x, Dec 2024 9.7x, Dec 2023 6.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (BG)
1 of 80 tracked investors hold BG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lee Ainslie | Maverick Capital | 0.04% | $4.3M | Added +66.9% |
Analysts (BG)
Consensus Buy (mean 1.78 on a 1–5 scale), 9 analysts; mean target USD 140.56 (low 116, high 155).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | JP Morgan | Target lowered | Overweight | $140 → $139 |
| 2026-09-10 | UBS | Target raised | Buy | $145 → $155 |
Total return (dividends reinvested) (BG)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +9.4% | +33.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +9.4% | +5.9% |
| Volatility (annualized) | 29.5% | 29.3% |
| Max drawdown | -21.7% (Jun 2026→Oct 2026) | -39.7% (Apr 2022→Feb 2025) |
BG analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.42 | $2.59 | -6.5% | $22.79B | 7 |
| Next quarter (ends Dec 2026) | $3.27 | $3.11 | +5.3% | $23.35B | 7 |
| Current fiscal year (ends Dec 2026) | $9.51 | $9.45 | +0.7% | $91.74B | 7 |
| Next fiscal year (ends Dec 2027) | $11.23 | $11.15 | +0.7% | $94.23B | 7 |
Key Statistics (as of October 23, 2026 at 10:12 UTC)
| Price | USD 103.15 |
|---|---|
| Change | ▲ 0.90% (up) |
| Previous Close | USD 102.23 |
| Open | USD 102.32 |
| Day Range | USD 100.5 – 103.2 |
| 52-Week Range | USD 88.24 – 134.87 |
| Volume | 1,332,021 shares |
| Market Cap | $19.82B |
| Exchange | NYQ |
Technical Analysis (BG)
Nexqual's technical model rates BG "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:12 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 37.43 (neutral) |
| vs SMA50 | Below (USD 112.33) |
| MACD | -2.61 (negative) |
Analyst Ratings (BG)
Wall Street analysts rate BG "Buy" based on 9 analysts, with a mean price target of USD 140.56 (range USD 116–155), per Nexqual as of October 23, 2026 at 10:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 140.56 |
| High Target | USD 155 |
| Low Target | USD 116 |
| Buy / Hold / Sell | 8 / 1 / 0 |
Earnings (BG)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 2.42 |
| Revenue Estimate | $22.79B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2 vs est 1.94 ▲ beat |
| 2026-03-31 | USD 1.83 vs est 0.87 ▲ beat |
| 2025-12-31 | USD 1.99 vs est 1.82 ▲ beat |
| 2025-09-30 | USD 2.27 vs est 1.97 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financials & Fundamentals (BG)
| Total Revenue | $91.82B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +88.30% |
| Gross Margin | +4.92% |
| Operating Margin | +4.62% |
| Profit Margin | +1.10% |
| ROE | +7.18% |
| Debt / Equity | 0.98 |
| Current Ratio | 1.57 |
| Total Cash | $788.00M |
| Total Debt | $17.06B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$711.00M (-0.8% of revenue) |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financial Health Score (BG)
Nexqual rates Bunge Global SA's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:12 UTC.
| Growth | Strong — Revenue +32% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 5%, operating 5% (last 12 months) |
| Balance Sheet | Mixed — $788M cash and investments vs $10.6B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$711M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Mixed — ROE 7%, ROA 3.5% |
Ownership (BG)
| Insider Ownership | +18.37% |
|---|---|
| Institutional Ownership | +80.54% |
| Shares Outstanding | 192.12M |
| Float | 157.58M |
| Short % of Float | +5.88% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Leadership (BG)
Bunge Global SA is led by Gregory A. Heckman, CEO & Director, per Nexqual as of October 23, 2026 at 10:12 UTC.
| CEO & Director | Gregory A. Heckman |
|---|---|
| Executive VP & CFO | John W. Neppl |
| Chief Operating Officer | Julio Garros |
| Vice President of Investor Relations | Mark Haden |
Major Backers & Investors (BG)
Notable institutional backers of Bunge Global SA include Glencore Plc, Canada Pension Plan Investment Board, Capital Group, according to Nexqual as of October 23, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Glencore Plc | 17.08% |
| Canada Pension Plan Investment Board | 13.66% |
| Capital Group | 10.12% |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 2.88% |
| Income Fund of America | 2.11% |
| NEW PERSPECTIVE FUND | 1.99% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.65% |
| BlackRock | 7.95% |
| State Street | 3.65% |
| Geode Capital | 1.9% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TSN | Tyson Foods, Inc. | USD 57.07 | ▲ 2.09% |
| ADM | Archer-Daniels-Midland Company | USD 79.84 | ▲ 0.6% |
| CALM | Cal-Maine Foods, Inc. | USD 63.83 | ▲ 5.31% |
| AGRO | Adecoagro S.A. | USD 9.83 | ▲ 3.69% |
| DMC | Del Monte Corporation | USD 29.93 | ▲ 7.28% |
| DOLE | Dole plc | USD 13.52 | ▲ 3.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt